Ruxolitinib does not impair humoral immune response to COVID-19 vaccination with BNT162b2 mRNA COVID-19 vaccine in patients with myelofibrosis

Caocci, Giovanni
First
;Mulas, Olga
Second
;Costa, Alessandro;Barabino, Luca;Greco, Marianna;La Nasa, Giorgio
Last
2022-01-01
2022
Files in This Item:
File Size Format  
Ruxolitinib does not impair humoral immune response to COVID‐19 vaccination with BNT162b2 mRNA COVID‐19 vaccine in patients with myelofibrosis.pdf

Solo gestori archivio

Type: versione editoriale
Size 369.24 kB
Format Adobe PDF
& nbsp; View / Open   Request a copy
369.24 kB Adobe PDF & nbsp; View / Open   Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Questionnaire and social

Share on:
Impostazioni cookie